Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Ipamorelin vs GHRP-2: Which Is Right for You?

Quick verdict Ipamorelin is prohibited for compounding with no pathway. GHRP-2 has complex status—Category 1 on 503B for non-injectable, non-nasal routes only; injectable use is not permitted. For legal injectable GH support, neither is a clear option; sermore

This comparison does not assign a generated winner or score.

  • Quick verdict
  • Ipamorelin is prohibited for compounding with no pathway. GHRP-2 has complex status—Category 1 on 503B for non-injectable, non-nasal routes only; injectable use is not permitted. For legal injectable GH support, neither is a clear option; sermorelin is the compoundable choice.
More references

Related material

Comparison

Side-by-Side Comparison

Class Growth Hormone Releasing Peptide Growth Hormone Secretagogue FDA Status Research Use Primary Uses Growth Hormone Release, Anti-Aging, Muscle Recovery growth hormone regulati…

View details →
Comparison

Cost Comparison

The economic considerations of Ipamorelin vs GHRP-2 therapy involve multiple factors including peptide synthesis costs, dosing requirements, and treatment duration. Historical pri…

View details →
Comparison

Effectiveness Comparison

Clinical efficacy data reveals significant differences in growth hormone-releasing potency between Ipamorelin and GHRP-2. In the landmark study by Raun et al., GHRP-2 at 1 mcg/kg …

View details →